CTRI/2021/06/034421Recruiting未知
A Comparative Study of Oral Cyclophosphamide vs Mycophenolate Mofetil in Children with Frequent Relapsing Steroid Dependent Nephrotic Syndrome
GURDEEP SINGH DHOORIA0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Children with Frequent Relapsing Steroid Dependent Nephrotic Syndrome
Exclusion Criteria
- •1. Congenital Nephrotic Syndrome
- •2. Steroid Resistant Nephrotic Syndrome
- •3. Patients with an estimated glomerular filtration rate ( <60 ml/min
- •per 1.73 m2
- •4. Known secondary causes including systemic lupus, Henoch
- •Schonlein purpura, IgA nephropathy or chronic infection (tuberculosis, HIV, hepatitis B or C.
- •5. Prior therapy with MMF, cyclosporine, tacrolimus, or cyclophosphamide in the past 6 months.
Investigators
Similar Trials
Active, not recruiting
Phase 1
Randomized phase III study of oral cyclophosphamide vs doxorubicin in 65 years or older patients with advanced or metastatic soft tissue sarcoma: a UNICANCER/GERICO multicenter programAdvanced or metastatic soft tissue sarcoma (STS) in patients =65 years old.EUCTR2018-000542-20-FRICANCER214
Completed
Not Applicable
Second Dutch Lupus Nephritis trialSystemic lupus erythematosusISRCTN34634478Sponsor not yet defined (The Netherlands)124
Not yet recruiting
Not Applicable
Effectiveness and safety of cyclophosphamide for older microscopic polyangiitis patients on induction therapyJPRN-UMIN000043514Department of Nephrology & Dialysis Kitano Hospital, Tazuke Kofukai Medical Research Institute35
Recruiting
Phase 4
Decreased immunosuppression in Primary Membranous NephropathyCTRI/2019/09/021287Postgraduate Institute of Medical Education and Research
Not yet recruiting
Phase 2
ow dose oral metronomic therapy in recurrent refractory uterine endometrial cancerCTRI/2024/07/070458Dr Bhoor Singh